"In a round about way is this Poster #2 saying that apabetalone has a positive affect on the mouse liver?"

That completely misses the point of the poster. You are referring to the data presented in panel 6 of the poster in which they investigated the ability of apabetalone to prevent the harmful effects of lipopolysaccharide (LPS)-induced endotoxemia on liver gene expression. In the abstract, they summarize these findings as "Acute endotoxemia is associated with activation of liver macrophages and endothelial cells and infiltration of immune cells. In mice exposed to 50 ug of LPS for 24h, apabetalone reduced liver mRNA marker expression for infiltrating monocytes, activated macrophages, and cellular adhesion (CD14, CCR2, ICAM and P-selectin)."

But that LPS liver data in panel 6 is only one small part of this poster. The other parts of the study investigate several facets of how apabetalone suppresses vascular inflammation and cell adhesion in endothelial cells and monocytes subjected to pro-inflammatory stimuli. Take another look at the abstract or poster to get the big picture.

BDAZ